FDA-Drug2014-01-29Class II
MYCOPHENOLATE MOFETIL, Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378225001.
Aidapak Services, LLC
Hazard
Labeling: Label Mixup: MYCOPHENOLATE MOFETIL, Capsule, 250 mg may have potentially been mislabeled as the following drug: PRAMIPEXOLE DI-HCL, Tablet, 0.25 mg, NDC 16714058501, Pedigree: W003761, EXP: 6/26/2014.
Sold states
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Affected count
100 Capsules
Manufactured in
14301 Se 1st St, Vancouver, WA, United States
Products
MYCOPHENOLATE MOFETIL, Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378225001.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-904-2014Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief